First image of the tested substance
First image of the tested substance
Second image of the tested substance
First image of the tested substance
Second image of the tested substance
Second image of the tested substance

Active ingredients and content

6-APB

Quantity not determinable

Details of the substance tested

Thickness

3.9 mm

Length x width

12.7 x 9.3 mm

Diameter

Weight

420.7 mg

Colour

Yellow

Colour

Fracture groove

Yes

Relevant substance(s)

Risk assessment

A pill declared as MDMA contained only the new psychoactive substance 6-APB (6-aminopropylbenzofuran) instead of MDMA.

6-APB belongs to the benzofuran group and was developed as a substitute for MDMA. The substance acts on similar neurotransmitter systems as MDMA and produces a similar effect. However, there is a risk of unexpected differences in effect, as 6-APB has a longer duration of action than MDMA. The potency and onset of effect can differ from MDMA, which can lead to premature re-dosing.

According to user reports, 6-APB causes nausea, headaches and a stronger "hangover" the next day more frequently than MDMA. 6-APB is a little-researched new psychoactive substance. There is no reliable information available on dosage, side effects, interactions, toxicity and long-term consequences. Its use is therefore not recommended.

Pills are often misdeclared; it is therefore essential to have them tested before use!

Alert level

Safer Use

Analysis

Have your substances tested in a Drug Checking

Testing

If you do not have the possibility to have substances analyzed, first test a maximum of one third of the pill, since very many high-dose pills are in circulation.

Wait and see

Wait 2 hours after taking the medication, as there are always pills with unexpected active ingredients in circulation, which can have a later onset of action.

Drinking

Remember: drink non-alcoholic and isotonic drinks (3 dl / hour) and take breaks in the fresh air from time to time to prevent overheating / dehydration.

Accept

Accept when the effect runs out, because "re-spiking" increases the toxicity (poisonousness) of MDMA.

Similar warnings

There are no current warnings for this substance

Things to know